Health TrialsbyHealthPanel

Managed Access Programs for BYL719, Alpelisib

ConditionsPIK3CA-Related Overgrowth Spectrum (PROS)Breast Cancer
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorNovartis Pharmaceuticals

About this trial

The purpose of this registration is to list Managed Access Programs (MAPs) related to BYL719, Alpelisib

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • alpelisib

    Drug

    Patients receive alpelisib

Treatment groups

No treatment groups listed

Trial outcomes

This trial has no outcomes listed.

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Novartis Pharmaceuticals

Lead sponsor

Source ClinicalTrials.gov
Apply now